Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Blank Rome Expands Privacy, Security & Data Protection Practice with Leading Team in California

Published

on

Orange County, CA, March 22, 2021 (GLOBE NEWSWIRE) — Blank Rome LLP is pleased to welcome three new attorneys to the firm’s Corporate, M&A, and Securities group, notably enhancing the firm’s Privacy, Security & Data Protection practice: partners Sharon R. Klein, who will serve as chair of the Privacy, Security & Data Protection practice, and Alex C. Nisenbaum, as well as associate Karen H. Shin. The prominent team will also establish a new office for Blank Rome in Orange County, California. They join Blank Rome from Troutman Pepper Hamilton Sanders LLP where Sharon led compliance for the Cybersecurity, Information Governance and Privacy practice group. 

“We are thrilled to welcome Sharon, Alex, and Karen to our firm as part of our strategic plan to grow our Privacy, Security & Data Protection practice, a critical area of focus for our firm as the data privacy landscape continues to rapidly evolve on a global scale,” said Grant S. Palmer, Blank Rome’s Managing Partner and CEO. “Across numerous industries, many businesses will need to carefully review and revise their privacy compliance plans, beyond just a litigation or regulatory focus. Sharon and Alex are nationally recognized for their work in this space, and the team’s collective high-level privacy and cybersecurity experience will be not only essential to our clients, but also to our attorneys across many practice areas who will be able to draw on their legal talent to provide enhanced client service offerings. In addition to growing our Privacy, Security & Data Protection practice, we are also excited to further expand Blank Rome’s presence on the West Coast with a new Orange County office—an important region for our clients and in alignment with our firm’s strategic growth plans.”  

“Sharon, Alex, and Karen will significantly expand our Privacy, Security & Data Protection practice capabilities and are the perfect team to lead the continued buildout of Blank Rome’s privacy and data security service offerings,” said Jennifer J. Daniels, a partner in the firm’s Corporate, M&A, and Securities group and a lead attorney in the Privacy, Security & Data Protection practice. “This area of law has become increasingly important for our clients due to a trend of state legislatures introducing comprehensive consumer privacy and biometric privacy bills, as well as the momentum toward a European standard of privacy and increased pressure on Congress to pass a federal privacy law. With Sharon at the helm of our practice, we are excited to offer our clients added depth and experience to our service offerings and capabilities.”

The team collectively advises clients on state, federal, and international data privacy and information security laws, regulations, and rules, including compliance with HIPAA/HITECH, Gramm-Leach-Bliley, and the California Consumer Privacy Act. They have significant experience assessing and mitigating risks related to the privacy and security of personal data; data ownership and commercialization of data; artificial intelligence; planning, auditing, drafting, and implementing privacy, security, and data protection policies and best practices; and breach response, crisis management, and investigation strategies for non-compliance. They are also well-versed in negotiating and drafting complex technology and cloud transactions, licensing, and strategic IT and commercial agreements. Their clients span a variety of industries, such as healthcare, consumer goods, e-commerce, FinTech, pharmaceutical, medical device, financial services, education, automotive, and manufacturing. Sharon and Alex are also both certified as information privacy professionals by the International Association of Privacy Professionals.

“Blank Rome has a strong team of experienced cybersecurity and data privacy attorneys, and we are eager to bring our practices together and form a robust, collaborative platform that will greatly benefit our clients’ evolving needs in this critical space,” said Klein. “In addition to expanding the team and practice offerings, we are excited to help launch the firm’s new Orange County office and we look forward to growing both the office and our presence in the region with leading talent.”

Nisenbaum continued, “We are committed to ensuring that our clients understand and mitigate the risks involved with use of data in their businesses. Our goal is to enable them to comply with regulations while still positioning themselves to leverage the value of that data. We look forward to working with our new Blank Rome colleagues to expand cybersecurity and data privacy offerings for clients, and to working with the firm’s experienced industry teams to further support our clients across a spectrum of legal needs.” 

Sharon brings more than 40 years’ experience to Blank Rome and is a known thought leader in data privacy, cybersecurity, and complex technology transactions. Her acumen in data privacy stems not only from her significant experience executing outsourcing and technology contracts, but also from the 12 years she spent as associate general counsel at Siemens Medical Solutions USA where she notably focused on operationalizing healthcare and life science regulations, including HIPAA/HITECH and the Common Rule. Sharon is active in many organizations, serving as a board member of the Girl Scouts of Orange County; a member of HIMSS (Healthcare Information and Management Systems Society); a commissioner of the Electronic Healthcare Network Accreditation Commission; and a member of the U.S. Department of Health and Human Services task force working to promote national cybersecurity standards. Sharon earned her J.D. from Temple University School of Law and her B.A., summa cum laude, Phi Beta Kappa, from Syracuse University.

Alex synthesizes the patchwork of state and federal legal requirements to assist clients in bringing innovative products to market and develop compliance programs that are in line with their business goals. He notably advises consumers and vendors of information technology products and services on commercial technology agreements involving cloud services and software licensing, software and mobile application development, information technology and business process outsourcing, hardware acquisition, telecommunications, data licensing, and professional services. Alex earned his J.D. from UCLA School of Law and his B.A. from the University of California, Los Angeles.

Karen focuses on a diverse range of data privacy and information security matters, including compliance with various privacy laws and regulations. She also assists clients in developing and implementing internal and external privacy policies as well as drafts various technology-related agreements and performs due diligence reviews. She is a member of the Orange County Korean American Bar Association. Karen earned her J.D. from the University of California, Irvine School of Law, and her B.A. from New York University.

About Blank Rome

Blank Rome is an Am Law 100 firm with 14 offices and more than 600 attorneys and principals who provide comprehensive legal and advocacy services to clients operating in the United States and around the world. Our professionals have built a reputation for their leading knowledge and experience across a spectrum of industries and are recognized for their commitment to pro bono work in their communities. Since our inception in 1946, Blank Rome’s culture has been dedicated to providing top-level service to all of our clients and has been rooted in the strength of our diversity and inclusion initiatives. For more information, please visit blankrome.com.

###

Attachment


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

THE 2024 GLOBAL EXPLORATION SUMMIT IS ANNOUNCED AT THE 120th EXPLORERS CLUB ANNUAL GALA IN NEW YORK

Published

on

the-2024-global-exploration-summit-is-announced-at-the-120th-explorers-club-annual-gala-in-new-york

Porto and Terceira Island to Host the ‘Davos of Exploration’ – The GLEX Summit
NEW YORK, April 24, 2024 /PRNewswire/ — The Explorers Club and Expanding World, are thrilled to announce the fifth edition of The GLEX Summit, known as the ‘Davos of Exploration,’ set to take place from June 15 to 19 on Porto city and Terceira Island in the Azores, Portugal.

This year, Porto will Ignite the summit, followed by two days of discussions and exploration in the historic city of Angra do Heroísmo on Terceira Island. From the depths of the oceans to new space missions, the power and future of exploration will be explored in these two World Heritage cities, deeply connected to the history of exploration.
The 2024 GLEX Summit will revolve around the latest discoveries and groundbreaking missions shaping the future of our planet. Highlights of the summit include the Artemis mission, which plans to send astronauts back to the moon for the first time since 1972, and the role of Space and the Oceans in researching and mitigating the effects of climate change. Notable sessions will also delve into the unfortunate incident of the submersible implosion that took place on Titan and the recording of an episode of the BBC’s acclaimed science comedy show ‘The Infinite Monkey Cage,’ hosted by physicist Brian Cox and comedian Robin Ince.
This prestigious event will bring together over three dozen explorer and scientist legends from around the world. Confirmed physicist and researcher Brian Cox, NASA Chief Scientist James Garvin, Aquanaut Fabien Cousteau, Oceanographer David Gallo, Cosmonaut Mike Massimino, Nasa ISS CapCom Tess Caswell, among many others global Explorers and Scientists.
For further inquiries about The GLEX Summit and press accreditation, please contact:
Marco Barbosa [email protected], +351917345744
Photo: https://mma.prnewswire.com/media/2395857/GLEX_Summit.jpg
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/the-2024-global-exploration-summit-is-announced-at-the-120th-explorers-club-annual-gala-in-new-york-302125563.html

Continue Reading

Artificial Intelligence

Hillstone Networks is Named in Microsegmentation Solutions Landscape Report

Published

on

hillstone-networks-is-named-in-microsegmentation-solutions-landscape-report

Hillstone Networks delivers advanced Microsegmentation across different verticals.. 
SANTA CLARA, Calif., April 24, 2024 /PRNewswire/ — Hillstone Networks, a leading provider of cybersecurity solutions, has been included in the Forrester Microsegmentation Solutions Landscape, Q2 2024 report. The report offers an overview of the Microsegmentation market, focused on the vendors who deliver solutions for protection of critical resources, combating ransomware, and contributing to compliance adherence. The report provides security professionals a snapshot of these named vendors, considering factors such as size, geographic focus, and use cases to select the most suitable option for their targeted use cases or needs. 

In the Landscape Report, Forrester states that “Zero Trust is all about replacing bodies of implicit trust with explicit policy. In physical and virtual networks, the application of this principle is referred to as microsegmentation…. [It] was one of the first true Zero Trust technologies developed after Forrester published the initial Zero Trust reports.”  
Forrester states in the report that the main trend is “organizations are finally getting serious about Zero Trust. Some, proactively, are implementing microsegmentation as part of a Zero Trust strategy or initiative. Others are implementing it because they got hit by ransomware and are trying to avoid it again. But all of them are doing Zero Trust with microsegmentation.”
“Being recognized as a vendor in the Microsegmentation solution landscape underscores for us the pivotal role our technology plays in safeguarding critical assets and thwarting ransomware threats. We believe it reaffirms our commitment to providing cutting-edge security measures built on an innovative and AI-powered platform that help our customers defend against evolving cyber risks, ensuring resilience and trust,” states Tim Liu, CTO and Co-founder at Hillstone Networks.
Hillstone’s Microsegmentation solution provides the following key benefits:
Advanced and extensive Microsegmentation for physical servers, virtual machines, cloud hosts, and containers, seamlessly compatible with multiple platforms.Comprehensive, integrated Layer 4 to 7 security and malware features (Next Generation Firewall, Intrusion Prevention System, AntiVirus, URL filtering, DDoS, and bot defense), and complete vulnerability management across the entire application lifecycle.Distributed architecture for easy scaling and portability.Centralized and comprehensive visibility to reduce gaps in the threat surface.Learn more about Hillstone Networks solutions here.
About Hillstone Networks
Hillstone Networks’ Integrative Cybersecurity approach is based on a visionary, AI-powered, and accessible platform, delivering coverage, control, and consolidation to secure over 28,000 global enterprises.
Media ContactZeyao Hu+1 [email protected]
Logo – https://mma.prnewswire.com/media/765968/Hillstone_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/hillstone-networks-is-named-in-microsegmentation-solutions-landscape-report-302125530.html

Continue Reading

Artificial Intelligence

Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System

Published

on

tetra-pharm-technologies-and-glysious-announce-collaboration-to-develop-transdermal-combination-drugs-targeting-the-endocannabinoid-system

The collaboration brings together Tetra Pharm Technologies’ expertise in enabling technology with Glysious’ proprietary transdermal drug delivery system, renowned for its effectiveness, comfort, and convenience.
COPENHAGEN, Denmark, April 24, 2024 /PRNewswire/ — Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies’ pipeline candidates. The joint invention aims to revolutionize transdermal release of “difficult-to-formulate” compounds targeting the endocannabinoid system.

Tetra Pharm Technologies has focused intensively on formulation expertise, that is, how the molecules are effectively integrated with a drug delivery system to reach their desired targets. Glysious has worked rigorously on the development of an adhesive patch for transdermal drug delivery since the company’s incorporation in 2020.
“The Glysious technology enables precision, sustained dosing, and allows for a high drug load and effective emptying of patches. The transdermal patches remain in place and are very comfortable and convenient to use, resulting in improved patient compliance. However, we have identified challenges with standard formulation strategies, not providing acceptable drug release due to shortcomings of the formulation matrix”, says Professor, Dr.Techn. Anne Ladegaard Skov, Chief Scientific Officer, Glysious.
Back in 2023 Glysious and Tetra Pharm Technologies performed early in-vitro feasibility tests, integrating Tetra Pharma Technologies’ proprietary enabling technology for delivery of poorly soluble compounds with Glysious’ patch.
Dr. Morten Allesø, Chief Scientific Officer, Tetra Pharm Technologies, adds: “Although both parties were aware of the uniqueness of our respective technologies, we were positively surprised to find a five-fold increase in performance of our combination product compared to conventional formulation technologies. This is truly remarkable, and we consider it our shared obligation to further advance this technology to the benefit of the patients.”
The objectives of the collaboration include conducting comprehensive in-vitro and in-vivo studies to evaluate the performance and efficacy of the combined drug delivery system. Additionally, Tetra Pharm Technologies and Glysious plan to pursue a common patent for the joint invention, ensuring that their innovative technology remains protected and exclusive.
“We are excited to collaborate with the innovative team in Tetra Pharm Technologies on this transdermal drug delivery system paving the way for commercialization and scaling of the Glysious technology within the pharma segment”, says Stina Bjerg Nielsen, Chief Executive Officer, Glysious.
Martin Rose, Chief Executive Officer, Tetra Pharm Technologies, concludes: “The collaboration represents a unique opportunity to harness the synergies between our respective technologies. By combining our expertise, we aim to develop a transdermal drug delivery system that offers superior efficacy, convenience, and patient compliance, supporting several of our pipeline programs”.
As part of the collaboration, the partners will exchange expertise, knowledge, and resources. In addition, Tetra Pharm Technologies and Glysious will conduct joint research, experiments, and tests as required for the development of a joint patent. The scope of the collaboration is focused on disease indications such as pain, sleep disorders, and appetite regulation.
About Tetra Pharm Technologies
Tetra Pharm Technologies is a Danish biopharmaceutical company established in 2018 with a vision to be a leader in research and development of pharmaceutical drugs for the treatment of diseases related to the endocannabinoid system. For more information, please visit www.tetrapharm.eu
About Glysious
Glysious is a Danish medtech company, incorporated in 2020, that develops patches, creams, spray, and foams with controlled release of active ingredients for cosmetics and life science applications. For more information, please visit www.glysious.com
For further informationJacob SchlundtChief Marketing OfficerTetra Pharm [email protected]+45 51976225
Stina Bjerg NielsenChief Executive [email protected]+45 3053 5393
Photo – https://mma.prnewswire.com/media/2393210/Tetra_Pharm_Technologies_Deal.jpgLogo – https://mma.prnewswire.com/media/1988863/Tetra_Pharm_Technologies_Logo.jpg
 
 
 

View original content:https://www.prnewswire.co.uk/news-releases/tetra-pharm-technologies-and-glysious-announce-collaboration-to-develop-transdermal-combination-drugs-targeting-the-endocannabinoid-system-302123136.html

Continue Reading

Trending